Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
- PMID: 27384994
- PMCID: PMC5226511
- DOI: 10.18632/oncotarget.10337
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
Abstract
Introduction: Multiple gene expression based prognostic biomarkers have been repeatedly identified in gastric carcinoma. However, without confirmation in an independent validation study, their clinical utility is limited. Our goal was to establish a robust database enabling the swift validation of previous and future gastric cancer survival biomarker candidates.
Results: The entire database incorporates 1,065 gastric carcinoma samples, gene expression data. Out of 29 established markers, higher expression of BECN1 (HR = 0.68, p = 1.5E-05), CASP3 (HR = 0.5, p = 6E-14), COX2 (HR = 0.72, p = 0.0013), CTGF (HR = 0.72, p = 0.00051), CTNNB1 (HR = 0.47, p = 4.3E-15), MET (HR = 0.63, p = 1.3E-05), and SIRT1 (HR = 0.64, p = 2.2E-07) correlated to longer OS. Higher expression of BIRC5 (HR = 1.45, p = 1E-04), CNTN1 (HR = 1.44, p = 3.5E- 05), EGFR (HR = 1.86, p = 8.5E-11), ERCC1 (HR = 1.36, p = 0.0012), HER2 (HR = 1.41, p = 0.00011), MMP2 (HR = 1.78, p = 2.6E-09), PFKB4 (HR = 1.56, p = 3.2E-07), SPHK1 (HR = 1.61, p = 3.1E-06), SP1 (HR = 1.45, p = 1.6E-05), TIMP1 (HR = 1.92, p = 2.2E- 10) and VEGF (HR = 1.53, p = 5.7E-06) were predictive for poor OS.
Materials and methods: We integrated samples of three major cancer research centers (Berlin, Bethesda and Melbourne datasets) and publicly available datasets with available follow-up data to form a single integrated database. Subsequently, we performed a literature search for prognostic markers in gastric carcinomas (PubMed, 2012-2015) and re-validated their findings predicting first progression (FP) and overall survival (OS) using uni- and multivariate Cox proportional hazards regression analysis.
Conclusions: The major advantage of our analysis is that we evaluated all genes in the same set of patients thereby making direct comparison of the markers feasible. The best performing genes include BIRC5, CASP3, CTNNB1, TIMP-1, MMP-2, SIRT, and VEGF.
Keywords: gastric cancer; meta-analysis; survival.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/5226511/fca7c3acef02/oncotarget-07-49322-g001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/5226511/390e60655b4d/oncotarget-07-49322-g002.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/5226511/929b95ecdd50/oncotarget-07-49322-g003.gif)
Similar articles
-
Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.Clin Cancer Res. 2014 May 1;20(9):2276-88. doi: 10.1158/1078-0432.CCR-13-1221. Epub 2014 Mar 6. Clin Cancer Res. 2014. PMID: 24602839
-
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.Histol Histopathol. 2008 Aug;23(8):917-23. doi: 10.14670/HH-23.917. Histol Histopathol. 2008. PMID: 18498066
-
Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.J Clin Pathol. 2013 Nov;66(11):937-45. doi: 10.1136/jclinpath-2013-201467. Epub 2013 Jul 13. J Clin Pathol. 2013. PMID: 23853314
-
Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8312-21. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674197 Free PMC article. Review.
-
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.Int J Cancer. 2016 Jan 1;138(1):87-97. doi: 10.1002/ijc.29684. Epub 2015 Jul 30. Int J Cancer. 2016. PMID: 26174627 Review.
Cited by
-
SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT.Cancer Rep (Hoboken). 2024 Jun;7(6):e2079. doi: 10.1002/cnr2.2079. Cancer Rep (Hoboken). 2024. PMID: 38923313 Free PMC article.
-
Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.Eur J Med Res. 2022 Aug 31;27(1):164. doi: 10.1186/s40001-022-00794-w. Eur J Med Res. 2022. PMID: 36045400 Free PMC article.
-
Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.Endocr Relat Cancer. 2016 Aug;23(8):609-23. doi: 10.1530/ERC-16-0086. Epub 2016 Jun 27. Endocr Relat Cancer. 2016. PMID: 27353038 Free PMC article.
-
Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.Biomed Res Int. 2020 Oct 1;2020:8931419. doi: 10.1155/2020/8931419. eCollection 2020. Biomed Res Int. 2020. PMID: 33062704 Free PMC article.
-
High FAM189B Expression and Its Prognostic Value in Patients with Gastric Cancer.Biomed Res Int. 2021 May 25;2021:8875971. doi: 10.1155/2021/8875971. eCollection 2021. Biomed Res Int. 2021. PMID: 34124264 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136:E359–386. - PubMed
-
- Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–267. - PubMed
-
- Climent M, Hidalgo N, Vidal O, Puig S, Iglesias M, Cuatrecasas M, Ramon JM, Garcia-Albeniz X, Grande L, Pera M. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2015 - PubMed
-
- Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, D'Angelo E, Dinapoli N, Nicolotti N, Valentini C, La Torre G. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiotherapy and oncology. 2009;92:176–183. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous